Silencing Aurora A leads to re-sensitization of breast cancer cells to Taxol through downregulation of SRC-mediated ERK and mTOR pathways.

about

Silencing Aurora A leads to re-sensitization of breast cancer cells to Taxol through downregulation of SRC-mediated ERK and mTOR pathways.

Item

http://www.wikidata.org/entity/Q46976280

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Silencing Aurora A leads to re ...... ediated ERK and mTOR pathways.

@en

Silencing Aurora A leads to re ...... ediated ERK and mTOR pathways.

@nl

type

Item

label

Silencing Aurora A leads to re ...... ediated ERK and mTOR pathways.

@en

Silencing Aurora A leads to re ...... ediated ERK and mTOR pathways.

@nl

prefLabel

Silencing Aurora A leads to re ...... ediated ERK and mTOR pathways.

@en

Silencing Aurora A leads to re ...... ediated ERK and mTOR pathways.

@nl

P1476

Silencing Aurora A leads to re ...... ediated ERK and mTOR pathways.

@en

P2093

Jindong Chen

http://www.w3.org/2001/XMLSchema#string

Ke Tang

http://www.w3.org/2001/XMLSchema#string

Wanqi Zhou

http://www.w3.org/2001/XMLSchema#string

Xiaoguang Chen

http://www.w3.org/2001/XMLSchema#string

Yan Li

http://www.w3.org/2001/XMLSchema#string

Zhiqiang Feng

http://www.w3.org/2001/XMLSchema#string

P2860

The role of Src in solid tumors

Aurora kinases as prognostic biomarkers in ovarian carcinoma.

Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer

Sensitizing the therapeutic efficacy of taxol with shikonin in human breast cancer cells

Nab-paclitaxel for the treatment of triple-negative breast cancer: Rationale, clinical data and future perspectives.

Aurora-A overexpression enhances cell-aggregation of Ha-ras transformants through the MEK/ERK signaling pathway

Dual blockade of phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways overcomes paclitaxel-resistance in colorectal cancer.

VX680/MK-0457, a potent and selective Aurora kinase inhibitor, targets both tumor and endothelial cells in clear cell renal cell carcinoma.

Roles of Aurora kinases in mitosis and tumorigenesis.

Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells

P304

2011-2022

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OR.2017.5908

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28849180

http://www.w3.org/2001/XMLSchema#string

P932

5652950

http://www.w3.org/2001/XMLSchema#string